Treatment with bisphosphonates associated with increased risk of atypical femoral fractures
Treatment with bisphosphonate therapy appears to be associated with an increased risk of atypical fractures of the femur, according to a report published Online First by Archives of Internal Medicine.
May 21, 2012
0
0